Merck said Chief Financial Officer Peter Kellogg will leave the pharmaceutical company in May and named Baxter executive Robert Davis as his successor.
from WSJ.com: US Business http://ift.tt/1j8uVUL
via IFTTT
from WSJ.com: US Business http://ift.tt/1j8uVUL
via IFTTT
No comments:
Post a Comment